Marginal zone lymphomas (MZLs) comprise 3 distinct entities: extranodal MZL of mucosa-associated lymphoid tissue (MALT), splenic MZL, and nodal MZL. Gastric MALT lymphoma is the most common extranodal MZL and often develops as a result of chronic Helicobacter pylori gastritis. Such cases frequently respond to antibiotics directed against H. pylori. Antigen-driven lymphomatous disease can also be seen in the association of Borrelia burgdorferi with MALT lymphoma of the skin, Chlamydia psittaci with MALT lymphoma of the ocular adnexa, Campylobacter jejuni with immunoproliferative disease of the small intestine, and hepatitis C with splenic MZL. This article discusses the pathogenesis and clinical features of MZL and the treatment options available to patients.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Correspondence: Alexandra M. Levine, MD, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Room 3468, Los Angeles, CA 90033. E-mail: email@example.com
ZuccaEBertoniFRoggeroE. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid tissue lymphoma of the stomach. N Engl J Med1998;338:804–810.
ThiedeCWundischTAlpenB. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol2001;19:1600–1609.
YeHLiuHAttygalleA. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood2003;102:1012–1018.
InagakiHNakamuraTLiC. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol2004;28:1560–1567.
LevyMCopie-BergmanCGameiroC. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol2005;23:5061–5066.
BayerdorfferENeubauerARudolphB. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection: MALT Lymphoma Study Group. Lancet1995;345:1591–1594.
de MascarelARuskone-FourmestrauxAVavergne-SloveA. Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch2005;446:219–224.
O'ConnerOAWrightJMoskowitzC. Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma. J Clin Oncol2005;23:676–684.
AudouinJLe TourneauAMolinaT. Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. Br J Haematol2003;122:404–412.
RosenwaldAOttGStilgenbauerS. Exclusive detection of the t(11:18)(q21;q21) in extra-nodal marginal zone B cell lymphomas (MZBK) of MALT type in contrast to other MZBL and extra-nodal large B cell lymphomas. Am J Pathol1999;155:1817–1821.
AlgaraPMateoMSSanchez-BeatoM. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood2002;99:1299–1304.